Literature DB >> 33290579

Automated gross tumor volume contour generation for large-scale analysis of early-stage lung cancer patients planned with 4D-CT.

Angela Davey1, Marcel van Herk1,2, Corinne Faivre-Finn1,3, Sean Brown1,3, Alan McWilliam1,2.   

Abstract

PURPOSE: Patients with early-stage lung cancer undergoing stereotactic ablative radiotherapy receive four-dimensional computed tomography (4D-CT) for treatment planning. Often, an internal gross target volume (iGTV), which approximates the motion envelope of a tumor over the breathing cycle, is delineated without defining a gross tumor volume (GTV). However, the GTV volume and shape are important parameters for prognostic and dose modelling, and there is interest in radiomic features extracted from the GTV and surrounding tissue. We demonstrate and validate a method to generate the GTV from an iGTV contour to aid retrospective analysis on routine data.
METHOD: It is possible to reconstruct the geometry of a tumor with knowledge of tumor motion and the motion envelope formed during respiration. To demonstrate this, the tumor motion path was estimated with local rigid registration, and the iGTV positioned incrementally at stations along the reverse path. It is shown that the tumor volume is the largest set common to the intersection of the iGTV at these positions, hence can be derived. This was implemented for 521 lung lesions on 4D-CT. Eleven patients with a GTV delineation performed by a radiation oncologist on a reference phase (50%) were used for validation. The generated GTV was compared to that delineated by the expert using distance-to-agreement (DTA), volume, and distance between centres of mass. An overall success rate was determined by detecting registration inaccuracy and performing a quality check on the routine iGTV. For successfully generated contours, GTV volume was compared to iGTV volume in a prognostic model for overall survival.
RESULTS: For the validation dataset, DTA mean (0.79 - 1.55 mm) and standard deviation (0.68 - 1.51 mm) were comparable to expected observer variation. Difference in volume was < 5 cm3 , and average difference in position was 1.21 mm. Deviations in shape and position were mainly caused by observer differences in iGTV and GTV interpretation as opposed to algorithm performance. For the complete dataset, an acceptable contour was generated for 94% of patients using statistical and visual assessment to detect failures. Generated GTV volumes improved prognostic model performance over iGTV volumes.
CONCLUSION: A method to generate a GTV from an iGTV and 4D-CT dataset was developed. This method facilitates data analysis of patients with early-stage lung cancer treated in the routine setting, that is, data mining, prognostic modeling, and radiomics. Generation failure detection removes the need for visual assessment of all contours, reducing a time-consuming aspect of big-data analysis. Favorable prognostic performance of generated GTV volumes over iGTV ones demonstrates opportunities to use this methodology for future study.
© 2020 The Authors. Medical Physics published by Wiley Periodicals LLC on behalf of American Association of Physicists in Medicine.

Entities:  

Keywords:  4D-CT; GTV; SABR; iGTV; lung cancer; swept volume; tumor motion

Mesh:

Year:  2020        PMID: 33290579      PMCID: PMC7986204          DOI: 10.1002/mp.14644

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  38 in total

1.  Target delineation variability and corresponding margins of peripheral early stage NSCLC treated with stereotactic body radiotherapy.

Authors:  Heike Peulen; José Belderbos; Matthias Guckenberger; Andrew Hope; Inga Grills; Marcel van Herk; Jan-Jakob Sonke
Journal:  Radiother Oncol       Date:  2015-03-11       Impact factor: 6.280

2.  4D CT amplitude binning for the generation of a time-averaged 3D mid-position CT scan.

Authors:  Matthijs F Kruis; Jeroen B van de Kamer; José S A Belderbos; Jan-Jakob Sonke; Marcel van Herk
Journal:  Phys Med Biol       Date:  2014-08-29       Impact factor: 3.609

Review 3.  Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer.

Authors:  Robert Timmerman; James Galvin; Jeff Michalski; William Straube; Geoffrey Ibbott; Elizabeth Martin; Ramzi Abdulrahman; Suzanne Swann; Jack Fowler; Hak Choy
Journal:  Acta Oncol       Date:  2006       Impact factor: 4.089

4.  Respiratory-driven lung tumor motion is independent of tumor size, tumor location, and pulmonary function.

Authors:  C W Stevens; R F Munden; K M Forster; J F Kelly; Z Liao; G Starkschall; S Tucker; R Komaki
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-09-01       Impact factor: 7.038

5.  The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.

Authors:  Zishan Allibhai; Mojgan Taremi; Andrea Bezjak; Anthony Brade; Andrew J Hope; Alexander Sun; B C John Cho
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-10-24       Impact factor: 7.038

6.  Use of Maximum Intensity Projections (MIPs) for target outlining in 4DCT radiotherapy planning.

Authors:  Rebecca Muirhead; Stuart G McNee; Carrie Featherstone; Karen Moore; Sarah Muscat
Journal:  J Thorac Oncol       Date:  2008-12       Impact factor: 15.609

7.  Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer.

Authors:  H Helen Liu; Peter Balter; Teresa Tutt; Bum Choi; Joy Zhang; Catherine Wang; Melinda Chi; Dershan Luo; Tinsu Pan; Sandeep Hunjan; George Starkschall; Isaac Rosen; Karl Prado; Zhongxing Liao; Joe Chang; Ritsuko Komaki; James D Cox; Radhe Mohan; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-29       Impact factor: 7.038

8.  Improvement of CT-based treatment-planning models of abdominal targets using static exhale imaging.

Authors:  J M Balter; K L Lam; C J McGinn; T S Lawrence; R K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-07-01       Impact factor: 7.038

9.  Delta-radiomics features for the prediction of patient outcomes in non-small cell lung cancer.

Authors:  Xenia Fave; Lifei Zhang; Jinzhong Yang; Dennis Mackin; Peter Balter; Daniel Gomez; David Followill; Aaron Kyle Jones; Francesco Stingo; Zhongxing Liao; Radhe Mohan; Laurence Court
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

10.  Application of the 3D slicer chest imaging platform segmentation algorithm for large lung nodule delineation.

Authors:  Stephen S F Yip; Chintan Parmar; Daniel Blezek; Raul San Jose Estepar; Steve Pieper; John Kim; Hugo J W L Aerts
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

View more
  1 in total

1.  Radial Data Mining to Identify Density-Dose Interactions That Predict Distant Failure Following SABR.

Authors:  Angela Davey; Marcel van Herk; Corinne Faivre-Finn; Alan McWilliam
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.